
Background: Dietitians play an important role in improving residents' health and quality of life in long-term care (LTC) homes. However, dietitians' global role is not well understood. Objective: To explore the role and involvement of dietitians in LTC homes globally, according to legislation, standards, guidelines and role statements. Methods: A cross-sectional document and website analysis was conducted. Countries listed on international dietetic websites were included, with documents eligible if dietitians were referenced in legislation, guidelines, or standards, or if role statements focused on LTC homes. Data were analysed using descriptive statistics, qualitative content analysis and quantitative comparative analysis. Results: Sixty-eight countries were identified, of which 37 (54%) had at least one document type. Role statements (n=28) were the most common type, followed by standards (n=10), legislation (n=8) and guidelines (n=6). Japan was the only country with all document types, followed by Australia, T & uuml;rkiye and Northern Ireland with three. Fourteen core topic areas were identified; dietitian services, nutrition care plans, nutrition support, malnutrition screening/diagnosis, food provision, menus, foodservice management, mealtime experience/dining environment, multidisciplinary collaboration, staff training, compliance, developing documents, quality improvement projects and committee involvement. Conclusion: Dietitian roles in LTC homes differ globally, reflecting variations in policy and practice. Many countries lack formal guidance, while others provide detailed frameworks. These disparities are shaped by demographic, cultural, systemic, economic and workforce factors that influence how LTC is structured. Stronger international coordination and national advocacy are needed to improve recognition of dietitians' roles and guide future policy supporting high-quality resident nutrition care and foodservice systems.
Background Impaired insight is common in schizophrenia and may influence the interpretation of patient-reported outcome measures, which are increasingly used in patient-centred care and research. However, little is known about how insight relates to self-reported symptom impact. This study examined this relationship in people with schizophrenia in community settings. Methods Latent class analysis was applied to responses from 162 participants on the Patient-Reported Impact of Symptoms in Schizophrenia (PRISS) scale. Sociodemographic, clinical and functional disability variables were analysed as predictors of class membership. Insight was assessed using the Positive and Negative Syndrome Scale (PANSS) G12 item in a subset of participants. Invariance analyses evaluated the consistency of the latent class structure across samples and gender. Results A four-class model was identified: Low symptom impact (50.62%); Disorganisation (26.54%); Suspiciousness (10.5%); and Severe (12.35%). The Severe clas showed a higher prevalence of clinician-rated negative symptoms. No association was observed between PANSS-G12-rated clinical insight and self-reported negative symptoms. The latent class structure was invariant across samples and gender, although women more frequently reported disturbance of volition, depression and feelings of guilt. Disability, psychological treatment and hospitalisation history were associated with class membership. Conclusions Findings suggest that impaired PANSS-G12-rated clinical insight is associated with greater self-reported impact of disorganisation and suspiciousness, but not with the self-reported impact of negative symptoms. Four distinct profiles of symptom impact were identified, with self-reported depression being more prevalent in the most severe profile. These findings may support patient-centred assessment in schizophrenia.
Calcific aortic valve disease (CAVD) involves interacting endothelial, interstitial, immune and extracellularmatrix programs, but public single-cell studies contain many cells and few donors. A staged, donor-aware computational workflow was applied to five public human transcriptomic datasets. GSE220774 was used for single-cell discovery; GSE51472, GSE194180 and GSE235995 for fixed-signature replication; and GSE306288 for donor-level spatial assessment. Donors or patients, rather than cells or spots, were treated as biological replicates. VIC9 ranked highest for a prespecified fibrocalcific composite, although reliable coverage was limited to two donors. Its CTHRC1/FAP/IBSP/CDKN2A core program increased across disease-stage, osteogenic-culture and independent patient datasets. FN1-NT5E was the only prespecified candidate pair detected above the 0.5% spot floor in all six spatial donors. Immediate-neighbor associations were positive in 6/6 donors (median Spearman rho = 0.0717; exact one-sided sign-test P = 0.015625) and remained directionally stable in sensitivity analyses. These results define a reproducible VIC9-like remodeling program and an FN1-rich, NT5E-associated spatial context. They are hypothesis-generating and do not establish direct binding, causal signaling, an irreversible VIC transition or a histologically defined calcification front.